JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 7, 2005; DOI: 10.1124/jpet.104.076497


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.076497v1
313/1/121    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaziri, N. D.
Right arrow Articles by Barton, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaziri, N. D.
Right arrow Articles by Barton, C. H.


Received for publication August 23, 2004.
Revised January 6, 2005.
Accepted for publication January 6, 2005.

Bradykinin Down-regulates Whereas Arginine Analogs Up-regulate eNOS Expression in Coronary Endothelial Cells

Nosratola D. Vaziri 1*, Y. Ding 2, Z. Ni 1, C. H. Barton 1

1 University of California, Irvine 2 Brown University, Providence, Rhode Island

* Address correspondence to: E-mail: ndvaziri{at}uci.edu

Abstract

Bradykinin (BK) is an endogenous vasoactive peptide that promotes vasodilation by stimulating the release of nitric oxide (NO) from endothelial cells via activation of endothelial NO synthase (eNOS). While the role of BK in modulation of eNOS activity is well understood, its possible effect on eNOS expression remains uncertain. Several studies have demonstrated negative feedback regulation of eNOS by NO. Therefore, we hypothesized that sustained stimulation with BK may down-regulate eNOS expression in endothelial cells. Human coronary endothelial cells were incubated for 24 hours with either BK alone or BK plus BK receptor type 1 or type 2 blockers. NO production and eNOS abundance (Western analysis) were determined. In separate experiments, cells were incubated with either an NOS inhibitor alone or in combination with BK. Incubation with BK caused a concentration-dependent rise in NO production and a dose-dependent decline in eNOS protein expression. These effects were abrogated by BK-2 blockade but were unaffected by BK-1 blockade. In contrast, NOS inhibitors lowered NO production and raised eNOS abundance in a dose-dependent fashion. The effects of BK on NO production and eNOS expression were abrogated by the NOS inhibitor. Thus, sustained activation of eNOS by BK results in a compensatory down-regulation of eNOS, whereas, its sustained inhibition leads to a compensatory up-regulation of eNOS. The observed modulations of eNOS expression are mediated by NO and represent an adaptive physiologic response.


Key words: ACE-inhibitors, NOS inhibitors, bradykinin, coronary arteries, endothelial cells, nitric oxide


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. D. Vaziri
Mechanisms of lead-induced hypertension and cardiovascular disease
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H454 - H465.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Zhang, E. G. Teggatz, A. Y. Zhang, M. J. Koeberl, F. Yi, L. Chen, and P.-L. Li
Cyclic ADP ribose-mediated Ca2+ signaling in mediating endothelial nitric oxide production in bovine coronary arteries
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1172 - H1181.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.